Industry
99d agoInsilico Moves AI Drug Discovery To Greenville
A $500 million valuation defines GNQ Insilico as it relocates its operations to Greenville. The firm leverages computational science and AI to identify treatments for cancer and metabolic diseases. This move expands the local biotech footprint.
The Signal
Practitioners should monitor how the company integrates its discovery pipeline into new regional research hubs.